Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of PPIL2 mRNA | affects cotreatment|decreases expression | 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of PPIL2 mRNA | affects cotreatment|decreases expression | 18164116
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PPIL2 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PPIL2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPIL2 mRNA | affects cotreatment|increases expression | 17942748
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of PPIL2 mRNA | decreases expression | 18548127
|
D012643 |
Selenium |
Selenium results in increased expression of PPIL2 mRNA | increases expression | 19244175
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PPIL2 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPIL2 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PPIL2 mRNA | increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.37 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.37 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
11.41 | 16434500 19061943 18056438 19052882 17162532 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.41 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.82 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.82 | 15668708 19142967 19103187 19221464 19289846 19115204 19200415 18629630 17440819 11161223 18425577 15565566 19084267 20135344 17261762 18855134 20859285 18351453 20390343 18997820 19288272 16818667 19487384 19155303 20005174 18815881 17049068 17893378 21152245 19011961 18984771 19244106 19410462 18821012 16873071 20065188 21138602 19189210 17242785 16202921 19189212 16273361 20544844 19059307 19066611 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.82 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.12 | 16807293 20514400 19701751 3084413 21159647 18056438 17428255 16569478 16288022 16502159 18506893 19418558 16830150 19052882 20935162 20214788 20007298 17761372 16779866 18393292 20512989 18971187 11831363 16935385 19171122 16328049 20101231 10737359 16698587 17055752 19107877 20727157 19822196 18788625 18978308 18665156 19519916 10672840 17162532 16681979 3581430 16878318 19394651 18691550 19335982 19208518 17173139 18210153 18494052 19919837 20084675 20432363 19383236 18785209 17978847 20524982 19539802 17138121 16540662 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.12 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.88 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.04 | 7505956 21159647 2727394 17174075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
10.17 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
10.17 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.07 | 17110522 16105132 17681005 15861022 17333356 16919318 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15340226 12621046 15668235 16354765 8697196 |
MESH:D003092 |
Colitis |
|
Selenium |
4.14 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 15322242 10048152 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.41 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.41 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.72 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.61 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.61 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.61 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.06 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.21 | 20544844 16202921 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.56 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
14.80 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.80 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
14.80 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.58 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.23 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 16354765 16959395 8697196 18606429 15340226 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
9.03 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
9.03 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.03 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.64 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.17 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.27 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.35 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.96 | 19638242 20032147 18407596 18665156 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.35 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.15 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
11.46 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
11.46 | 19850985 2422723 19427195 19642983 12112319 19294768 19073162 20452335 19833225 15175105 19426721 19551842 9163691 20501860 15885732 18648771 19255062 21071580 19256749 19638242 19996281 19812893 20583210 2862719 20137499 18644402 19499222 20101389 21278145 19254457 19690152 20118626 21167192 18978307 10737359 19090486 20492335 18977376 20405173 18754104 16942905 20434301 21047994 12771043 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
11.46 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.46 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.82 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.82 | 19126423 18544905 18282651 2563599 18164116 19004024 21159647 19009564 18093689 18775883 16842330 18079962 17942915 17174075 18253720 9362446 18308698 16267830 3124819 19539802 17854601 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.82 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.51 | 20970405 6695378 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.51 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.60 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.60 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.88 | 15107826 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
6.04 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
6.04 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19189210 19196722 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.57 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.56 | 20387270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.50 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.33 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.80 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11118676 11896295 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
3.41 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.41 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 15861022 16919318 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.09 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.09 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.19 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.44 | 16712894 17572228 8653321 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |